SGH
EXAS

Sivik Global Healthcare’s Exact Sciences EXAS Stock Holding History

Sivik Global Healthcare’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-20,000
Closed -$2.36M – 50
2019
Q2 		$2.36M Buy
+20,000
New +$2.02M 0.57% 51

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Sivik Global Healthcare's EXAS Position: Q3 2019 in Review

Sivik Global Healthcare sold out of Exact Sciences (EXAS) in Q3 2019, closing a stake of 20,000 shares — an estimated $2.36M sold.

Sivik Global Healthcare first reported a position in EXAS in Q2 2019 and held it in 1 quarter. The position peaked at $2.36M in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

  • Sivik Global Healthcare reported no remaining Exact Sciences position as of Q3 2019 after selling out during the quarter.
  • Sivik Global Healthcare sold 20,000 Exact Sciences shares in Q3 2019, an estimated $2.36M.
  • Sivik Global Healthcare first reported a position in Exact Sciences in Q2 2019 and held it in 1 quarter.
  • Sivik Global Healthcare's Exact Sciences position peaked at $2.36M in Q2 2019.
  • 475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Sivik Global Healthcare's 13F filing for Q3 2019, filed 12 Nov 2019.